Evidence map›Paper›PMID 8529676›Full record

ArticleEuropean journal of pediatrics1995

Serial cardiorespiratory exercise testing in patients with congenital heart disease.

T Reybrouck, R Rogers, M Weymans, M Dumoulin, M Vanhove, W Daenen, L Van der Hauwaert, M Gewillig

2 registry-linked trialsAbstract read
PubMed Publisher
In one paragraph

Article in European journal of pediatrics, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02138435 completednot on this mapstarted 2014, after this paper: background citation

Cardiac Output During Exercise in Young Adults Operated for Ventricular Septal Defect as Children

TypeobservationalSponsorUniversity of AarhusRan2014 to 2016Enrolled40ConditionsVentricular Septal DefectArmsMRI exercise test, Gas-exchange exercise test
NCT02914652 phase4completednot on this mapstarted 2016, after this paper: background citation

The Cardiopulmonary Effect of Inhaled Beta-2-agonists on Adult Ventrucular Septal Defect Patients With Persistant or Surgically Corrected Conditions - The VENTI Trial

TypeinterventionalSponsorUniversity of AarhusRan2016 to 2018Enrolled96ConditionsVentricular Septal DefectArmsSalbutamol, Norflouran (Placebo Evohaler(R) )
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Article
  4. Review
  5. Mechanism of Dyspnea during Exercise in Children with Corrected Congenital Heart Disease.International journal of environmental research and public health · 2021
    Article
  6. Article
  7. Article
  8. Cardiopulmonary exercise testing in congenital heart disease: (contra)indications and interpretation.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2009
    Article
  9. Article
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

T ReybrouckDepartment of Cardiovascular Rehabilitation, Gasthuisberg University Hospital, Leuven, Belgium.
R Rogers
M Weymans
M Dumoulin
M Vanhove
W Daenen
L Van der Hauwaert
M Gewillig

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aerobic capacity of patients with different forms of congenital heart disease was serially evaluated in 79 patients and the evolution was correlated with the lesion and the level of daily activity. The patients were divided into six groups: patients with a small ventricular septal defect (VSD) with mini shunt (n = 14), mild pulmonary valve stenosis with gradient < 40 mm Hg (PS) (n = 12), mild to moderate aortic valve stenosis (gradient 36 +/- 17 mmHg) (AS) (n = 12), patients 4.7 +/- 2.1 years after repair of tetralogy of Fallot (PO-TF) (n = 16), patients 2.2 +/- 2.9 years after closure of a high flow/high gradient VSD (PO-VSD) (n = 13), and patients 2.6 +/- 1.7 years after Fontan repair (Fontan-PO) (n = 12). Aerobic capacity was assessed by determination of the ventilatory anaerobic threshold (VAT). VAT reflects the highest aerobic exercise level prior to a disproportionate increase of CO2 and ventilation relative to O2 uptake; it is independent of patient motivation. Data are expressed as percentage of normal O2 uptake at VAT, determined in 234 age/gender matched controls. The habitual level of physical activity was assessed by a standardised questionnaire. Aerobic capacity in all subgroups of patients, even with very mild defects, was at or below the lower limit of normal. Children left unrestricted from physical exercise (VSD, PS, PO-VSD) had no change over the study period. However, aerobic capacity of patients with medically imposed physical restrictions (AS) and significant residual haemodynamic lesions (PO-TF, Fontan) decreased with age.(ABSTRACT TRUNCATED AT 250 WORDS)

Indexed as

Exercise TestAdolescentAnaerobic ThresholdCarbon DioxideChildChild, PreschoolDisability EvaluationFemaleFollow-Up StudiesFontan ProcedureHeart Defects, CongenitalHemodynamicsHumansMaleOxygenPostoperative ComplicationsCarbon DioxideOxygen

Identifiers

PMID8529676

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.